Lapatinib ditosylate GlaxoSmithKline.
作者信息
Kim Tracy E, Murren John R
机构信息
449 S Doheny Drive, Beverly Hills, CA 90211, USA.
出版信息
IDrugs. 2003 Sep;6(9):886-93.
PMID:12964069
Abstract
Lapatinib ditosylate, an ErbB-2 and EGFR dual tyrosine kinase inhibitor, is being developed by GlaxoSmithKline plc for the potential treatment of solid tumors.
摘要
Zotero 插件